Physicians as whistleblowers: Doctors get rich by exposing fraud

by McAfee & Taft

As the federal and state governments have evolved from Uncle Sam to Doctor Sam, the potential for healthcare waste, fraud and abuse has also increased. One way the government has deterred healthcare fraud is by enacting and bolstering whistleblower laws. Federal whistleblower laws provide legal claims for individuals who discover or suspect violations of law, corporate waste, corruption, or abuse by companies doing business with the government. In the healthcare industry, increasing numbers of whistleblower claims are being made by physicians.

Whistleblower claims are usually brought as qui tam actions arising under state or federal law. The federal False Claims Act is often referred to as the federal government’s primary tool for recovering funds lost as a result of fraud against the government.

Originally enacted in 1863 to combat fraud in the Civil War, the False Claims Act has always contained its qui tam provisions, which allow a private citizen to bring claims as a private attorney general. The Act provides that a party who submits false claims or who submits false statements to get claims paid is liable for treble damages, plus civil penalties ranging from $5,500 to $11,000 per false claim. Whistleblowers are incentivized to bring such claims. If the government is successful in recovering in a qui tam case, the whistleblower is entitled to receive a percentage of the government’s recovery, which can be substantial given the damages and penalties. Successful whistleblowers are also entitled to recover their attorney fees.

In fiscal year 2013, the U.S. Department of Justice recovered more than $3.8 billion under the False Claims Act, nearly $2.9 billion of which resulted from qui tam cases brought by whistleblowers. Of the $3.8 billion recovered, $2.6 billion came from healthcare cases. The DOJ recovered $5.69 billion in fiscal year 2014.

Qui tam lawsuits are different from most other types of lawsuits. First, they are filed under seal so that the government can investigate the claims and decide whether to prosecute the lawsuit. Generally, the whistleblower must be the first to file the claim and must be the original source of the information provided to the government.

Whistleblower claims in the healthcare industry have become commonplace, particularly in matters relating to Medicare or Medicaid compliance. These claims can involve a range of practices, such as billing, coding and claims submissions by hospitals, surgery centers, medical device manufacturers, medical group practices, nursing homes, or others. They can also arise based on prohibited referrals under the Stark law and illegal kickback arrangements involving healthcare providers, physicians or others. Unexpectedly, a number of qui tam plaintiffs have been physicians.

Healthcare industry executives should be cognizant that physicians may become whistleblowers. In addition to promoting an environment of legal compliance and requiring compliance with laws, healthcare industry executives should be thoughtful when making remarks to physicians about healthcare regulatory compliance matters. The message should be one of promoting and assuring compliance, not a message of taking transactions to the edge. There’s a great difference between “we promote legal compliance” and “we want to comply with the spirit of the law.”

Fraudulent or abusive practices in the healthcare industry can be difficult to detect. Often physicians are knowledgeable about wrongful practices as a result of their involvement in meetings, discussions with other physicians and healthcare executives, and access to documents and information. Physicians can provide information about practices, transactions and arrangements that industry self-reporting or government detection may not reveal. They are considered reliable sources of information and are presumed to be credible because of their status as physicians and their medical knowledge to explain technical information. As a result, when physicians come forward as qui tam plaintiffs, prosecutors will listen, even though the claims may involve a drumbeat of innuendoes, repetition of charges that are not adequately supported by accurate facts, or opportunistic maneuvering.

Physician whistleblowers are motivated to bring qui tam actions for various reasons, including:

  • Financial incentives available to qui tam plaintiffs;
  • Disagreements and adversarial relationships with other physicians and healthcare providers;
  • Exclusion from participation in business transactions, joint ventures, and arrangements in which other physicians may profit or benefit;
  • Competitive concerns;
  • Anger or disgruntlement following the termination of employment, revocation of medical staff appointment, or expulsion from joint venture participation;
  • Perceived “self-preservation” or protection as a threat to other physicians or healthcare providers who assert claims or take actions against them;
  • Poor treatment by healthcare executives;
  • Protecting patients and patient safety;
  • Stopping unlawful or fraudulent practices;
  • Exposing wrongdoing.

Some recent examples of physician whistleblower FCA cases:

  • A court recently entered judgments for an amount in excess of $276 million after a physician brought claims under the False Claims Act against an organization that was operating an outpatient surgery center that offered specialist physicians part-time employment contracts in excess of the fair market value for their services so that the physicians would have to provide outpatient procedures at the organization’s hospital and would not perform their endoscopies at a recently opened, competing facility.
  • In January 2014, an operator of numerous hospitals in Kentucky agreed to pay $16.5 million to settle allegations that it submitted false claims to the Medicare and Kentucky Medicaid programs for cardiac procedures that were not medically necessary. In addition to the allegations that physicians, with the knowledge of the hospital, performed numerous invasive but medically unnecessary cardiac procedures, the government further claimed that the hospital entered into sham management agreements as kickbacks that incentivized doctors to refer more patients to the hospitals. The case began with qui tam lawsuits initiated by three cardiologists who will receive $2.46 million of the settlement funds.
  • A nonprofit healthcare organization operating a network of hospitals in the South and Midwest paid $5.4 million to resolve claims that it violated the False Claims Act by providing radiation oncology services to Medicare and TRICARE beneficiaries that were not directly supervised by radiation oncologists or similarly qualified persons. The allegations were made by a radiation oncologist and former employee of a radiation oncology group at one of the organization’s hospitals. The physician received $1,082,500 as his share of the recovery.
  • A provider of chemotherapy infusion treatments agreed to pay $3.7 million to settle allegations that it improperly extended the duration of treatments and provided unnecessary office visits to evaluate patients prior to their receiving infusion services. The case was initially brought by a physician-whistleblower who recovered more than $280,000 for his role as a whistleblower.
  • In 2013, after three physicians alleged in a qui tam case that a pediatric practice with 13 medical offices knowingly upcoded claims submitted to Tennessee’s Medicaid program for infant auditory screening exams, the physician who was the majority shareholder and managing officer of the practice pleaded guilty to a misdemeanor count of healthcare fraud and also entered into a civil settlement. As part of the settlement, the physician was excluded from participation in all federal healthcare programs for 20 years and was required to pay criminal restitution and damages totaling more than $1.6 million.

Now, some organizations even support, encourage and promote medical professionals as qui tam plaintiffs. For example, Medical Whistleblower Advocacy Network is an advocacy organization that provides support to physician whistleblowers who assert claims in the name of protecting patients and preserving human rights. A number of law firms also advertise their services to physicians as potential qui tam plaintiffs against pharmaceutical companies and medical device manufacturers.

Physicians who bring whistleblower claims, once discovered, may be characterized as troublemakers or disruptive to an organization’s operations. They may even be ostracized by colleagues. Recently, however, physician whistleblowers have included prominent medical professionals, including hospital chiefs of staff, respected physicians who repeatedly complain about patient safety problems, academic department chairs, and mainstream physicians with support from other physicians.

New whistleblower protections and claims were included in the Affordable Care Act. Section 1558 of the Affordable Care Act prohibits employers from discharging or discriminating against an employee with respect to compensation, terms, conditions or other privileges of employment because the employee (a) has provided or is about to provide to the employer, the federal government, or the attorney general of a state information relating to any violation of any provision of the Affordable Care Act; (b) testified or is about to testify in a proceeding concerning such violation; (c) assisted or participated, or is about to assist or participate, in such a proceeding; or (d) objected to, or refused to participate in, any activity, policy, practice or assigned task that the employee reasonably believed to be in violation of any provision of the Affordable Care Act.

Healthcare providers should have a whistleblower policy in place. The policy should make it clear that it is the responsibility of employees to report their concerns about possible violations of policies, unethical conduct, or violations of law. It should include a consistent protocol that maintains the attorney-client privilege during the provider’s investigation and incorporates provisions to assure compliance with Section 1558 of the Affordable Care Act. Also, it should provide that individuals submitting a report will not be subjected to retaliation, intimidation, harassment or other adverse action for reporting a possible violation in good faith or cooperating in the investigation of a possible violation.

In addition, hospital executives, medical group managers, physician executives, and other healthcare industry officials should be judicious when making comments to physicians and others about regulatory compliance issues. They should make it clear that organizational policy requires compliance. Statements made during meetings with physician groups that the organization is “pushing the envelope,” “taking the law to the limit,” “taking advantage of gray areas,” “pressing the lawyers to stretch the law,” or “looking for loopholes” should be avoided, considering that a member of the audience could become a qui tam plaintiff.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McAfee & Taft | Attorney Advertising

Written by:

McAfee & Taft

McAfee & Taft on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.